| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lexie Zhiyan Jin, Anna Rangan, Jesper Mehlsen, Lars Bo Andersen, Sofus C Larsen, Berit L Heitman. Association Between Use of Cannabis in Adolescence and Weight Change into Midlife. PloS one. vol 12. issue 1. 2017-08-15. PMID:28060830. |
cannabis use has been found to stimulate appetite and potentially promote weight gain via activation of the endocannabinoid system. |
2017-08-15 |
2023-08-13 |
Not clear |
| Isabelle Boileau, Esmaeil Mansouri, Belinda Williams, Bernard Le Foll, Pablo Rusjan, Romina Mizrahi, Rachel F Tyndale, Marilyn A Huestis, Doris E Payer, Alan A Wilson, Sylvain Houle, Stephen J Kish, Junchao Ton. Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [ Biological psychiatry. vol 80. issue 9. 2017-08-09. PMID:27345297. |
fatty acid amide hydrolase binding in brain of cannabis users: imaging with the novel radiotracer [ one of the major mechanisms for terminating the actions of the endocannabinoid anandamide is hydrolysis by fatty acid amide hydrolase (faah), and inhibitors of the enzyme were suggested as potential treatment for human cannabis dependence. |
2017-08-09 |
2023-08-13 |
human |
| Laurel Dezieck, Zachary Hafez, Albert Conicella, Eike Blohm, Mark J O'Connor, Evan S Schwarz, Michael E Mullin. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series. Clinical toxicology (Philadelphia, Pa.). vol 55. issue 8. 2017-08-07. PMID:28494183. |
cannabinoid hyperemesis syndrome (chs) is characterized by symptoms of cyclic abdominal pain, nausea, and vomiting in the setting of prolonged cannabis use. |
2017-08-07 |
2023-08-13 |
Not clear |
| Heather B Clayton, Richard Lowry, Carmen Ashley, Amy Wolkin, Althea M Gran. Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana. Pediatrics. vol 139. issue 4. 2017-08-03. PMID:28289138. |
health risk behaviors with synthetic cannabinoids versus marijuana. |
2017-08-03 |
2023-08-13 |
Not clear |
| Heather B Clayton, Richard Lowry, Carmen Ashley, Amy Wolkin, Althea M Gran. Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana. Pediatrics. vol 139. issue 4. 2017-08-03. PMID:28289138. |
the purpose of this study was to compare the behavioral risk correlates of synthetic cannabinoid use with those among marijuana users. |
2017-08-03 |
2023-08-13 |
Not clear |
| Joana Couceiro, Susana Bandarra, Haider Sultan, Suzanne Bell, Susana Constantino, Alexandre Quinta. Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell lines. Forensic science international. vol 264. 2017-08-01. PMID:27054591. |
the emergence and abuse of synthetic cannabinoids has been increasing as an alternative to cannabis, mainly among youth. |
2017-08-01 |
2023-08-13 |
human |
| Diana Dow-Edwards, Lindsay Silv. Endocannabinoids in brain plasticity: Cortical maturation, HPA axis function and behavior. Brain research. vol 1654. issue Pt B. 2017-07-31. PMID:27569586. |
therefore, exogenous cannabinoids, such as marijuana, have the potential to alter the course of development of each of these major systems (limbic, hypothalamic-pituitary-adrenal (hpa) axis and neocortex) if used during the critical period of brain development, adolescence. |
2017-07-31 |
2023-08-13 |
Not clear |
| Ryan Vandrey, Evan S Herrmann, John M Mitchell, George E Bigelow, Ronald Flegel, Charles LoDico, Edward J Con. Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes. Journal of analytical toxicology. vol 41. issue 2. 2017-07-28. PMID:28158482. |
quantitative levels of cannabinoids in whole blood and oral fluid were low compared with levels observed following inhalation of cannabis. |
2017-07-28 |
2023-08-13 |
Not clear |
| Hemant Goyal, Umesh Singla, Urvashi Gupta, Elizabeth Ma. Role of cannabis in digestive disorders. European journal of gastroenterology & hepatology. vol 29. issue 2. 2017-07-20. PMID:27792038. |
cannabis sativa, a subspecies of the cannabis plant, contains aromatic hydrocarbon compounds called cannabinoids. |
2017-07-20 |
2023-08-13 |
Not clear |
| Hemant Goyal, Umesh Singla, Urvashi Gupta, Elizabeth Ma. Role of cannabis in digestive disorders. European journal of gastroenterology & hepatology. vol 29. issue 2. 2017-07-20. PMID:27792038. |
the present review sheds light on the role of cannabis in the gut, liver, and pancreas and also on other gi symptoms, such as nausea and vomiting, cannabinoid hyperemesis syndrome, anorexia, weight loss, and chronic abdominal pain. |
2017-07-20 |
2023-08-13 |
Not clear |
| Anna Chiarlone, Christine Börner, Laura Martín-Gómez, Ada Jiménez-González, Adrián García-Concejo, María L García-Bermejo, Mar Lorente, Cristina Blázquez, Elena García-Taboada, Amador de Haro, Elisa Martella, Volker Höllt, Raquel Rodríguez, Ismael Galve-Roperh, Jürgen Kraus, Manuel Guzmá. MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling. Neuropharmacology. vol 108. 2017-07-18. PMID:27179908. |
cannabinoid cb1 receptor, the molecular target of endocannabinoids and cannabis active components, is one of the most abundant metabotropic receptors in the brain. |
2017-07-18 |
2023-08-13 |
mouse |
| Oier Aizpurua-Olaizola, Iratxe Zarandona, Laura Ortiz, Patricia Navarro, Nestor Etxebarria, Aresatz Usobiag. Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis. Drug testing and analysis. vol 9. issue 4. 2017-07-18. PMID:27341312. |
a high performance liquid chromatography coupled to tandem mass spectrometry (hplc-ms/ms) method for simultaneous quantification of Δ9-tetrahydrocannabinol (thc), its two metabolites 11-hydroxy-Δ9-tetrahydrocannabinol (11-oh-thc) and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (thc-cooh), and four additional cannabinoids (cannabidiol (cbd), cannabigerol (cbg), tetrahydrocannabivarin (thcv), and cannabinol (cbn)) in 1 ml of human urine and plasma was developed and validated. |
2017-07-18 |
2023-08-13 |
human |
| Charles D Ciccon. Medical Marijuana: Just the Beginning of a Long, Strange Trip? Physical therapy. vol 97. issue 2. 2017-07-17. PMID:27660328. |
various species of the marijuana plant have been cultivated, and this plant can contain up to 100 active compounds known as cannabinoids. |
2017-07-17 |
2023-08-13 |
Not clear |
| Charles D Ciccon. Medical Marijuana: Just the Beginning of a Long, Strange Trip? Physical therapy. vol 97. issue 2. 2017-07-17. PMID:27660328. |
two cannabinoids seem the most clinically relevant: Δ9-tetrahydrocannabinol (thc), which tends to produce the psychotropic effects commonly associated with marijuana, and cannabidiol (cbd), which may produce therapeutic effects without appreciable psychoactive properties. |
2017-07-17 |
2023-08-13 |
Not clear |
| Charles D Ciccon. Medical Marijuana: Just the Beginning of a Long, Strange Trip? Physical therapy. vol 97. issue 2. 2017-07-17. PMID:27660328. |
smoking marijuana, or ingesting extracts from the whole plant orally (in baked goods, teas, and so forth), introduces variable amounts of thc, cbd, and other minor cannabinoids into the systemic circulation, where they ultimately reach the central and peripheral nervous systems. |
2017-07-17 |
2023-08-13 |
Not clear |
| Charles D Ciccon. Medical Marijuana: Just the Beginning of a Long, Strange Trip? Physical therapy. vol 97. issue 2. 2017-07-17. PMID:27660328. |
although there is still a need for randomized controlled trials, preliminary studies have suggested that medical marijuana and related cannabinoids may be beneficial in treating people with chronic pain, inflammation, spasticity, and other conditions seen commonly in physical therapist practice. |
2017-07-17 |
2023-08-13 |
Not clear |
| Charles D Ciccon. Medical Marijuana: Just the Beginning of a Long, Strange Trip? Physical therapy. vol 97. issue 2. 2017-07-17. PMID:27660328. |
clinicians also should be aware that marijuana can produce untoward effects on cognition, coordination, balance, and cardiovascular and pulmonary function and should be vigilant for any problems that may arise if patients are using cannabinoids during physical rehabilitation. |
2017-07-17 |
2023-08-13 |
Not clear |
| Małgorzata Pokrywka, Joanna Góralska, Bogdan Solnic. Cannabinoids - a new weapon against cancer? Postepy higieny i medycyny doswiadczalnej (Online). vol 70. issue 0. 2017-07-17. PMID:28100841. |
the isolation and characterization of the structure of one of the main active ingredients of cannabis - Δ9 - tetrahydrocannabinol as well the discovery of its cannabinoid binding receptors cb1 and cb2, has been a milestone in the study of the possibilities of the uses of cannabis sativa and related products in modern medicine. |
2017-07-17 |
2023-08-13 |
Not clear |
| Agnieszka Zakrzeska, Tomasz Grędziński, Wioleta Kisiel, Ewa Chabielsk. Cannabinoids and haemostasis. Postepy higieny i medycyny doswiadczalnej (Online). vol 70. issue 0. 2017-07-10. PMID:27383573. |
the range of biological functions of endo- and plant cannabinoids, expanded to include the process of hemostasis, may constitute a condition for their recognition as a new factor responsible for thromboembolism in smokers of marijuana, in pathological disorders with increased levels of endocannabinoids and in individuals with polymorphisms of faah c385a and a385a. |
2017-07-10 |
2023-08-13 |
Not clear |
| Lisa K Brent. Marijuana, the Endocannabinoid System and the Female Reproductive System. The Yale journal of biology and medicine. vol 89. issue 2. 2017-07-05. PMID:27354844. |
marijuana, the endocannabinoid system and the female reproductive system. |
2017-07-05 |
2023-08-13 |
human |